In spring 2025, there was a major change in leadership at the Department of Health and Human Services when Robert F. Kennedy, Jr. became Secretary. One of his controversial decisions was to remove 17 members from the CDC’s Advisory Committee on Immunization Practices (ACIP), raising concerns about conflicts of interest and proper oversight in vaccine recommendations.
1. ACIP's Role and Responsibility: ACIP is responsible for vaccine recommendations in the United States, influencing school entry requirements, federal programs, and spending. Members are required to act without industry influence, which includes both disclosing conflicts and avoiding decisions tied to personal or institutional interests.
2. Conflict of Interest Issues: Many ACIP members have disclosed financial connections to vaccine manufacturers but have still participated in discussions and votes about vaccines related to those companies. Examples include:
• Dr. Cody Meissner voted on vaccine recommendations while having funding ties with several vaccine manufacturers.
• Dr. Tamera Coyne-Beasley made similar conflicts known but voted on policies involving Merck without recusal.
• Dr. Janet Englund abstained from only one of several votes though she had numerous ties to industry funders.
3. Recent Examples of Conflicts: Current members like Dr. Bonnie Maldonado disclosed conflicts but voted on policies while these conflicts remained. This trend has raised serious questions about the enforcement of recusal policies.
4. Importance of True Recusal: While many members disclosed conflicts, participation in discussions can still influence outcomes, challenging the integrity of the decision-making process. Guidelines clearly state that individuals with conflicts must remove themselves not just from voting but also discussion.
5. Independence and Trust: The removal of the 17 members highlighted systemic issues with relying on conflicted experts to regulate products linked to their funding. Sustaining public trust in health recommendations requires clear separation between commercial interests and scientific advisory roles.
The recent leadership changes at HHS and subsequent actions regarding ACIP members underline the need for stricter conflict of interest management in vaccine policy development. Moving forward, ACIP must not only recognize but actively prevent conflicts to ensure trust and integrity in public health recommendations.
https://brownstone.org/articles/former-vaccine-committee-did-not-follow-the-rules/
No comments:
Post a Comment